» Articles » PMID: 35655710

Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes

Overview
Journal Alcohol Res
Specialty Psychiatry
Date 2022 Jun 3
PMID 35655710
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The endogenous cannabinoid system is involved in several physiological functions in the central nervous system including the modulation of brain reward circuitry and emotional homeostasis. Substantial evidence implicates brain endocannabinoid signaling in the processing of drug-induced reward states, wherein repeated exposure besets pathological changes in activity that contribute to the progression of alcohol use disorder. This review provides a narrative summary of recent studies exploring the interaction between alcohol exposure and changes in endocannabinoid signaling that may underlie the development of alcohol use disorder.

Search Methods: The authors began with an initial search for review articles to assist in the identification of relevant literature. This was followed by separate searches for primary literature and recent studies. The search terms "alcohol/ethanol" and "endocannabinoids" were applied, along with terms that covered specific objectives in reinforcement and addiction behavior. The content was further refined by excluding articles containing a broad focus on psychiatric disorders, polysubstance abuse, non-cannabinoid signaling lipids, and other criteria.

Search Results: The initial search yielded a total of 49 review articles on PubMed, 13 on ScienceDirect, and 17 on Wiley Online, from which the authors garnered information from a total of 16 reviews. In addition to independent searches, this review provides information from a collection of 212 publications, including reviews and original research articles.

Discussion And Conclusions: The review discusses the effects of alcohol consumption on brain endocannabinoid signaling, including alcohol-based perturbations in endocannabinoid-mediated synaptic transmission, the modulation of alcohol-related behaviors by manipulating signaling elements of the endocannabinoid system, and the influence of dysregulated endocannabinoid function in promoting withdrawal-induced anxiety-like behavior. Notable emphasis is placed on studies exploring the possible therapeutic relevance of bolstering brain endocannabinoid tone at different stages of alcohol use disorder.

Citing Articles

Chronic intermittent ethanol produces nociception through endocannabinoid-independent mechanisms in mice.

Miliano C, Dong Y, Proffit M, Corvalan N, Natividad L, Gregus A bioRxiv. 2025; .

PMID: 39975399 PMC: 11838487. DOI: 10.1101/2024.11.08.622656.


The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder.

Miliano C, Natividad L, Quello S, Stoolmiller M, Gregus A, Buczynski M Biol Psychiatry Glob Open Sci. 2024; 4(6):100368.

PMID: 39282655 PMC: 11400622. DOI: 10.1016/j.bpsgos.2024.100368.


The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice.

Raghav J, Kumar H, Ji L, Vemuri K, Makriyannis A, Suh J Psychopharmacology (Berl). 2023; 241(3):427-443.

PMID: 38001264 DOI: 10.1007/s00213-023-06500-w.


Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.

Augustin S, Gracias A, Luo G, Anumola R, Lovinger D Neuropsychopharmacology. 2023; 48(13):1941-1951.

PMID: 37528221 PMC: 10584873. DOI: 10.1038/s41386-023-01671-8.


Experience with dronabinol consumption facilitated a stimulant effect of alcohol and affected alcohol-related changes in frontal cortical endocannabinoid levels in male rats.

Sangiamo D, Weingarten M, Nelson N, Choi C, Das A, Liang N Behav Brain Res. 2023; 452:114587.

PMID: 37467963 PMC: 10528712. DOI: 10.1016/j.bbr.2023.114587.


References
1.
Hansson A, Bermudez-Silva F, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R . Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology. 2006; 32(1):117-26. DOI: 10.1038/sj.npp.1301034. View

2.
Marsicano G, Lutz B . Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest. 2006; 29(3 Suppl):27-46. View

3.
Basavarajappa B, Saito M, Cooper T, Hungund B . Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta. 2000; 1535(1):78-86. DOI: 10.1016/s0925-4439(00)00085-5. View

4.
van Esbroeck A, Janssen A, Cognetta 3rd A, Ogasawara D, Shpak G, van der Kroeg M . Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. Science. 2017; 356(6342):1084-1087. PMC: 5641481. DOI: 10.1126/science.aaf7497. View

5.
Natividad L, Steinman M, McGinn M, Sureshchandra S, Kerr T, Ciccocioppo R . Impaired hypothalamic feedback dysregulates brain glucocorticoid signaling in genetically-selected Marchigian Sardinian alcohol-preferring rats. Addict Biol. 2020; 26(3):e12978. PMC: 8052265. DOI: 10.1111/adb.12978. View